Clinical Trials · NCT01714648
Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Elisha Hospital
- Enrollment
- 6
- Start date
- Nov 2012
- Locations
- 1 site, Israel
- Primary endpoint
- Number of Participants with Adverse Events as a Measure of Safety: The adverse event is the development of OHSS following oocyte retrieval.